{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:40:06Z","timestamp":1793947206580,"version":"4.8.0"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Acute encephalopathy is a constellation of syndromes in which immune response, metabolism and neuronal excitation are affected in a variable fashion. Most of the syndromes are complex disorders, caused or aggravated by multiple, genetic and environmental risk factors. Environmental factors include pathogenic microorganisms of the antecedent infection such as influenza virus, human herpesvirus-6 and enterohemorrhagic\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    , and drugs such as non-steroidal anti-inflammatory drugs, valproate and theophylline. Genetic factors include mutations such as rare variants of the\n                    <jats:italic>SCN1A<\/jats:italic>\n                    and\n                    <jats:italic>RANBP2<\/jats:italic>\n                    genes, and polymorphisms such as thermolabile\n                    <jats:italic>CPT2<\/jats:italic>\n                    variants and\n                    <jats:italic>HLA<\/jats:italic>\n                    genotypes. By altering immune response, metabolism or neuronal excitation, these factors complicate the pathologic process. On the other hand, some of them could provide promising targets to prevent or treat acute encephalopathy.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2023.1119708","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:43Z","timestamp":1674518443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Genetic and environmental risk factors of acute infection-triggered encephalopathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Masashi","family":"Mizuguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamaneurol.2020.2687","article-title":"Neurologic and radiographic findings associated with COVID-19 infection in children.","volume":"77","author":"Abdel-Mannan","year":"2020","journal-title":"JAMA Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.braindev.2010.04.002","article-title":"Early infantile manifestations of incontinentia pigmenti mimicking acute encephalopathy.","volume":"33","author":"Abe","year":"2011","journal-title":"Brain Dev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.braindev.2016.01.007","article-title":"Manifestations and characteristics of congenital adrenal hyperplasia-associated encephalopathy.","volume":"38","author":"Abe","year":"2016","journal-title":"Brain Dev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues.","volume":"369","author":"Aguet","year":"2020","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.seizure.2022.06.012","article-title":"Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.","volume":"100","author":"Aledo-Serrano","year":"2022","journal-title":"Seizure"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0020177","article-title":"RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.","volume":"2","author":"Aslanukov","year":"2006","journal-title":"PLoS Genet."},{"key":"B7","first-page":"1779","article-title":"Valproic acid-induced hyperammonemic encephalopathy: MR appearance.","volume":"15","author":"Baganz","year":"1994","journal-title":"AJNR Am. J. Neuroradiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/humu.23550","article-title":"De novo variants in RHOBTB2, an atypical Rho GTPase gene, cause epileptic encephalopathy.","volume":"39","author":"Belal","year":"2018","journal-title":"Hum. Mutat."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reye\u2019s syndrome in the United States from 1981 through 1997.","volume":"340","author":"Belay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.braindev.2011.08.001","article-title":"Immunomodulatory therapy in recurrent acute necrotizing encephalopathy ANE1: Is it useful?","volume":"34","author":"Bergamino","year":"2012","journal-title":"Brain Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S1474-4422(06)70446-X","article-title":"De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study.","volume":"5","author":"Berkovic","year":"2006","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1772","article-title":"Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.","volume":"9","author":"Biela","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.febslet.2005.02.050","article-title":"Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy.","volume":"579","author":"Chen","year":"2005","journal-title":"FEBS Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1007\/s00018-012-1071-9","article-title":"Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","volume":"69","author":"Cho","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/dmcn.12927","article-title":"Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.","volume":"57","author":"Dard","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0733-8619(18)31058-2","article-title":"Reye syndrome.","volume":"3","author":"De Vivo","year":"1985","journal-title":"Neurol. Clin."},{"key":"B17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/106002809302700510","article-title":"Valproate-induced coma: Case report and literature review.","volume":"27","author":"Duarte","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","article-title":"Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.","volume":"138","author":"Emery","year":"2009","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.braindev.2014.10.001","article-title":"A case of recurrent encephalopathy with SCN2A missense mutation.","volume":"37","author":"Fukasawa","year":"2015","journal-title":"Brain Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1528-1167.2009.02382.x","article-title":"Adenosine A1 receptor blockage mediates theophylline-associated seizures.","volume":"51","author":"Fukuda","year":"2010","journal-title":"Epilepsia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.seizure.2010.11.012","article-title":"Activation of central adenosine A(2A) receptors lowers the seizure threshold of hyperthermia-induced seizure in childhood rats.","volume":"20","author":"Fukuda","year":"2011","journal-title":"Seizure"},{"key":"B23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archneur.60.4.605","article-title":"Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation.","volume":"60","author":"Hanemann","year":"2003","journal-title":"Arch. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-2008-1071440","article-title":"EEG features and their evolution in the acute phase of haemorrhagic shock and encephalopathy syndrome.","volume":"22","author":"Harden","year":"1991","journal-title":"Neuropediatrics"},{"key":"B25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1442-200X.2003.01662.x","article-title":"Intravenous glycerol should not be used in patients with unrecognized fructose-1,6-giphosphate deficiency.","volume":"45","author":"Hasegawa","year":"2003","journal-title":"Pediatr. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.braindev.2008.11.013","article-title":"The role of interleukin-1\u03b2 in febrile seizures.","volume":"31","author":"Heida","year":"2009","journal-title":"Brain Dev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clim.2006.01.005","article-title":"A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy.","volume":"119","author":"Hidaka","year":"2006","journal-title":"Clin. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.braindev.2016.09.014","article-title":"\u201cSymptomatic\u201d infection-associated acute encephalopathy in children with underlying neurological disorders.","volume":"39","author":"Hirayama","year":"2017","journal-title":"Brain Dev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1212\/wnl.42.3.666","article-title":"Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.","volume":"42","author":"Honeycutt","year":"1992","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/gene.2016.32","article-title":"Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy.","volume":"17","author":"Hoshino","year":"2016","journal-title":"Genes Immun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.braindev.2011.07.012","article-title":"Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.","volume":"34","author":"Hoshino","year":"2012","journal-title":"Brain Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/01.inf.0000160995.07461.b8","article-title":"Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy.","volume":"24","author":"Hosoya","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1007\/s10072-022-06033-8","article-title":"A novel variation in RANBP2 associated with infection-triggered familial acute necrotizing encephalopathy.","volume":"43","author":"Hu","year":"2022","journal-title":"Neurol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pediatrneurol.2020.03.002","article-title":"Acute necrotizing encephalopathy due to Streptococcus pneumoniae: An uncommon pathogen in a devastating disease.","volume":"108","author":"Huber","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJM198510033131403","article-title":"Public Health Service study on Reye\u2019s syndrome and medications. Report of the pilot phase","volume":"313","author":"Hurwitz","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1442-200x.2003.01822.x","article-title":"Serum cytokine concentrations of influenza-associated acute necrotizing encephalopathy.","volume":"45","author":"Ichiyama","year":"","journal-title":"Pediatr. Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/0036554021000026986","article-title":"Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy.","volume":"35","author":"Ichiyama","year":"","journal-title":"Scand. J. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ng0896-485","article-title":"Mutations in the TRKA\/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis.","volume":"13","author":"Indo","year":"1996","journal-title":"Nat. Genet."},{"key":"B39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-323-53088-0.00006-3","article-title":"Genetic background of encephalopathy","author":"Ishii","year":"2018","journal-title":"Acute encephalopathy and encephalitis in infancy and its related disorders"},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510x(96)00152-9","article-title":"Serial magnetic resonance images in a patient with congenital sensory neuropathy with anhidrosis and complications resembling heat stroke.","volume":"142","author":"Iwanaga","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1038\/sj.onc.1203784","article-title":"SPAK, a STE20\/SPS1-related kinase that activates the p38 pathway.","volume":"19","author":"Johnston","year":"2000","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncpneuro0883","article-title":"Roles of the cation-chloride cotransporters in neurological disease.","volume":"4","author":"Kahle","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.taap.2009.04.014","article-title":"Diclofenac enhances proinflammatory cytokine-induced nitric oxide production through NF-kappaB signaling in cultured astrocytes.","volume":"238","author":"Kakita","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acn3.372","article-title":"Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy.","volume":"4","author":"Kambouris","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04576-y","article-title":"GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"12","author":"Kasai","year":"","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41435-022-00170-y","article-title":"Protective association of HLA-DPB1*04:01:01 with acute encephalopathy with biphasic seizures and late reduced diffusion identified by HLA imputation.","volume":"23","author":"Kasai","year":"","journal-title":"Genes Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.braindev.2020.04.006","article-title":"Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014-2017.","volume":"42","author":"Kasai","year":"2020","journal-title":"Brain Dev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/s0140-6736(86)92714-5","article-title":"Valproate toxicity and ornithine carbamoyltransferase deficiency.","volume":"2","author":"Kay","year":"1986","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neulet.2005.04.097","article-title":"Genetic susceptibility to simple febrile seizures: Interleukin-1b promoter polymorphisms are associated with sporadic cases.","volume":"384","author":"Kira","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpeds.2016.02.080","article-title":"Clinical features of carnitine deficiency secondary to pivalate-conjugated antibiotic therapy.","volume":"173","author":"Kobayashi","year":"2016","journal-title":"J. Pediatr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.eplepsyres.2012.04.016","article-title":"Acute encephalopathy with a novel point mutation in the SCN2A gene.","volume":"102","author":"Kobayashi","year":"2012","journal-title":"Epilepsy Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","article-title":"Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS.","volume":"32","author":"Koenning","year":"2012","journal-title":"J. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2019.04.009","article-title":"Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood.","volume":"98","author":"Koh","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.braindev.2013.07.012","article-title":"Marked elevation of interleukin-6 in mild encephalopathy with a reversible splenial lesion (MERS) associated with acute focal bacterial nephritis caused by Enterococcus faecalis.","volume":"36","author":"Kometani","year":"2014","journal-title":"Brain Dev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1442-200X.2007.02524.x","article-title":"Theophylline-associated seizures and their clinical characterizations.","volume":"50","author":"Korematsu","year":"2008","journal-title":"Pediatr. Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00251-012-0604-6","article-title":"IL1RN genetic variations and risk of IPF: A meta-analysis and mRNA expression study.","volume":"64","author":"Korthagen","year":"2012","journal-title":"Immunogenetics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.braindev.2010.12.012","article-title":"Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children.","volume":"34","author":"Kubota","year":"2012","journal-title":"Brain Dev."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120010","article-title":"MRI findings at neurological onset predict neurological prognosis in hemorrhagic shock and encephalopathy syndrome.","volume":"430","author":"Kuki","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.25125","article-title":"MYRF is associated with encephalopathy with reversible myelin vacuolization.","volume":"83","author":"Kurahashi","year":"2018","journal-title":"Ann. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","article-title":"Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome.","volume":"78","author":"LaRovere","year":"2021","journal-title":"JAMA Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s0140-6736(86)91947-1","article-title":"Is Reye\u2019s syndrome caused by augmented release of tumor necrosis factor?","volume":"2","author":"Larrick","year":"1986","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102194","article-title":"Genetic acute necrotizing encephalopathy associated with RANBP2: Clinical and therapeutic implications in pediatrics.","volume":"43","author":"Levine","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2352-4642(20)30362-X","article-title":"Neuroimaging manifestations in children with SARS-CoV-2 infection: A multinational, multicentre collaborative study.","volume":"5","author":"Lindan","year":"2021","journal-title":"Lancet Child Adolesc. Health"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00123","article-title":"Verotoxin receptor-based pathology and therapies.","volume":"10","author":"Lingwood","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1600-0404.2003.00227.x","article-title":"Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.","volume":"109","author":"Lokrantz","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1542\/peds.2007-0339","article-title":"Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid.","volume":"120","author":"Makino","year":"2007","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00234-002-0773-3","article-title":"Concentric structure of thalamic lesions of acute necrotizing encephalopathy.","volume":"44","author":"Mizuguchi","year":"2002","journal-title":"Neuroradiology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.braindev.2020.08.001","article-title":"Guidelines for the diagnosis and treatment of acute encephalopathy in childhood.","volume":"43","author":"Mizuguchi","year":"2021","journal-title":"Brain Dev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s004010100384","article-title":"Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2.","volume":"102","author":"Mizuguchi","year":"2001","journal-title":"Acta Neuropathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0404.2007.00809.x","article-title":"Acute encephalopathy associated with influenza and other viral infections.","volume":"115","author":"Mizuguchi","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"B71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1474-4422(10)70214-3","article-title":"Acute encephalopathy with inflammation-mediated status epilepticus.","volume":"10","author":"Nabbout","year":"2011","journal-title":"Lancet Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/INF.0b013e318162a13b","article-title":"Prognostic factors in influenza-associated encephalopathy.","volume":"27","author":"Nagao","year":"2008","journal-title":"Infect. Dis. J."},{"key":"B73","first-page":"371","article-title":"Theophylline-induced seizures: Clinical and pathophysiologic aspects.","volume":"138","author":"Nakada","year":"1983","journal-title":"West. J. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajhg.2008.12.009","article-title":"Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2.","volume":"84","author":"Neilson","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/01.wnl.0000073544.28775.1a","article-title":"Autosomal dominant acute necrotizing encephalopathy.","volume":"61","author":"Neilson","year":"2003","journal-title":"Neurology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.10849","article-title":"Autosomal dominant acute necrotizing encephalopathy maps to 2q12.1-2q13.","volume":"55","author":"Neilson","year":"2004","journal-title":"Ann. Neurol."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01646-8","article-title":"Acute encephalopathy in children with tuberous sclerosis complex.","volume":"16","author":"Numoto","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","article-title":"The blood-brain barrier and epilepsy.","volume":"47","author":"Oby","year":"2006","journal-title":"Epilepsia"},{"key":"B79","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3346\/jkms.2004.19.3.426","article-title":"Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children.","volume":"19","author":"Oh","year":"2004","journal-title":"J. Korean Med. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.braindev.2021.04.009","article-title":"Recurrent acute necrotizing encephalopathy in a boy with RANBP2 mutation and thermolabile CPT2 variant: The first case of ANE1 in Japan.","volume":"43","author":"Ohashi","year":"2021","journal-title":"Brain Dev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.braindev.2011.11.002","article-title":"Sporadic hemiplegic migraine presenting as acute encephalopathy.","volume":"34","author":"Ohmura","year":"2012","journal-title":"Brain Dev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.braindev.2021.07.008","article-title":"Increased cytokines\/chemokines and hyponatremia as a possible cause of clinically mild encephalitis\/encephalopathy with a reversible splenial lesion associated with acute focal bacterial nephritis.","volume":"44","author":"Okada","year":"2022","journal-title":"Brain Dev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1348-0421.2009.00124.x","article-title":"Acute necrotizing encephalopathy: A comparison between influenza and non-influenza cases.","volume":"53","author":"Okumura","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03311.x","article-title":"Acute encephalopathy in children with Dravet syndrome.","volume":"53","author":"Okumura","year":"2012","journal-title":"Epilepsia"},{"key":"B85","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1023\/a:1007649815992","article-title":"Hepatotoxicity due to mitochondrial dysfunction.","volume":"15","author":"Pessayre","year":"1999","journal-title":"Cell. Biol. Toxicol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2352-4642(21)00193-0","article-title":"Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: A prospective national cohort study.","volume":"5","author":"Ray","year":"2021","journal-title":"Lancet Child Adolesc. Health"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-8-43","article-title":"Hemorrhagic shock and encephalopathy syndrome\u2013the markers for an early HSES diagnosis.","volume":"8","author":"Rinka","year":"2008","journal-title":"BMC Pediatr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.braindev.2014.07.010","article-title":"Clinical and genetic features of acute encephalopathy in children taking theophylline.","volume":"37","author":"Saitoh","year":"","journal-title":"Brain Dev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2015.08.001","article-title":"Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.","volume":"117","author":"Saitoh","year":"","journal-title":"Epilepsy Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jns.2016.07.040","article-title":"Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES\/AERRPS.","volume":"368","author":"Saitoh","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1528-1167.2011.03402.x","article-title":"Mutations of the SCN1A gene in acute encephalopathy.","volume":"53","author":"Saitoh","year":"2012","journal-title":"Epilepsia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","article-title":"Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1\u03b2 production in vitro.","volume":"47","author":"Santtila","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2012.01.017","article-title":"Diffusion tensor imaging and magnetic resonance spectroscopy of transient cerebral white matter lesions in X-linked Charcot-Marie-Tooth disease.","volume":"316","author":"Sato","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy.","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"B95","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.braindev.2016.02.007","article-title":"Variable clinical course in acute necrotizing encephalopathy and identification of a novel RANBP2 mutation.","volume":"38","author":"Sell","year":"2016","journal-title":"Brain Dev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.braindev.2019.07.008","article-title":"Thermolabile polymorphism of carnitine palmitoyltransferase 2: A genetic risk factor of overall acute encephalopathy.","volume":"41","author":"Shibata","year":"2019","journal-title":"Brain Dev."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.891721","article-title":"Association of IL-1B rs16944 polymorphism with acute encephalopathy with biphasic seizures and late reduced diffusion is opposite to that of febrile seizures.","volume":"13","author":"Shibata","year":"2022","journal-title":"Front. Neurol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136173","article-title":"RANBP2 mutation causing autosomal dominant acute necrotizing encephalopathy attenuates its interaction with COX11.","volume":"763","author":"Shibata","year":"2021","journal-title":"Neurosci. Lett."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116808","article-title":"Case-control association study of rare nonsynonymous variants of SCN1A and KCNQ2 in acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"414","author":"Shibata","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2006.07.002","article-title":"Acute encephalopathy with refractory status epilepticus: Bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage.","volume":"250","author":"Shiihara","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.braindev.2018.05.010","article-title":"An episode of acute encephalopathy with biphasic seizures and late reduced diffusion followed by hemiplegia and intractable epilepsy observed in a patient with a novel frameshift mutation in HNRNPU.","volume":"40","author":"Shimada","year":"2018","journal-title":"Brain Dev."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/WNL.0b013e31828f18d8","article-title":"ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus.","volume":"80","author":"Shinohara","year":"2013","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.braindev.2010.09.002","article-title":"Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases.","volume":"33","author":"Shinohara","year":"2011","journal-title":"Brain Dev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1111\/j.1528-1167.2011.03193.x","article-title":"Acute-onset epilepsy triggered by fever mimicking FIRES (febrile infection-related epilepsy syndrome): The role of protocadherin 19 (PCDH19) gene mutation.","volume":"52","author":"Specchio","year":"2011","journal-title":"Epilepsia"},{"key":"B105","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1196\/annals.1320.004","article-title":"Carnitine deficiency disorders in children.","volume":"1033","author":"Stanley","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2007-990265","article-title":"A case of primary erythermalgia, wintry hypothermia and encephalopathy.","volume":"38","author":"Takahashi","year":"2007","journal-title":"Neuropediatrics"},{"key":"B107","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.braindev.2009.02.012","article-title":"Two newly proposed infectious encephalitis\/encephalopathy syndromes.","volume":"31","author":"Takanashi","year":"2009","journal-title":"Brain Dev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00234-015-1573-x","article-title":"Disrupted glutamate-glutamine cycle in acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"57","author":"Takanashi","year":"2015","journal-title":"Neuroradiology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/01.wnl.0000210487.36667.a5","article-title":"Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy.","volume":"66","author":"Takanashi","year":"2006","journal-title":"Neurology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3174\/ajnr.A1247","article-title":"Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"30","author":"Takanashi","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1528-1167.2010.02600.x","article-title":"Acute encephalopathy with a truncation mutation in the SCN1A gene: A case report.","volume":"51","author":"Takayanagi","year":"2010","journal-title":"Epilepsia"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/j.1528-1167.2011.03019.x","article-title":"Encephalopathy and SCN1A mutations.","volume":"52","author":"Tang","year":"2011","journal-title":"Epilepsia"},{"key":"B113","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1006\/taap.1997.8313","article-title":"Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: Implications for the pathogenesis of Reye\u2019s syndrome.","volume":"147","author":"Trost","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archpedi.156.6.545","article-title":"Polymorphisms for interleukin 1\u03b2 exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions.","volume":"156","author":"Tsai","year":"2002","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"B115","first-page":"15","article-title":"Evidence of a theophylline-induced vitamin B6 deficiency caused by noncompetitive inhibition of pyridoxal kinase.","volume":"113","author":"Ubbink","year":"1989","journal-title":"Lab. Clin. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1023\/a:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy.","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy.","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: Experimental and clinical evidence.","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"B119","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF01956748","article-title":"Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia.","volume":"152","author":"Vianey-Saban","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/03602539508998334","article-title":"Reye\u2019s and Reye-like syndromes, drug-related diseases? (Causative agents, etiology, pathogenesis, and therapeutic approaches).","volume":"27","author":"Visentin","year":"1995","journal-title":"Drug Metab. Rev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0883073815604227","article-title":"A review of X-linked Charcot-Marie-Tooth Disease.","volume":"31","author":"Wang","year":"2016","journal-title":"J. Child Neurol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1528-1157.1983.tb03428.x","article-title":"Sodium valproate associated with phenobarbital: Effects on ammonia metabolism in humans.","volume":"24","author":"Warter","year":"1983","journal-title":"Epilepsia"},{"key":"B123","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jiac.2018.04.007","article-title":"Acute focal bacterial nephritis characterized by acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"24","author":"Yamaguchi","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pediatrneurol.2011.04.010","article-title":"Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation.","volume":"45","author":"Yamazaki","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/humu.20717","article-title":"Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy.","volume":"29","author":"Yao","year":"2008","journal-title":"Hum. Mutat."},{"key":"B126","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ymgme.2011.07.009","article-title":"Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy.","volume":"104","author":"Yao","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"B127","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-0404.2007.00810.x","article-title":"First-line therapy for theophylline-associated seizures.","volume":"186","author":"Yoshikawa","year":"2007","journal-title":"Acta Neurol. Scand. Suppl"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10072-018-3449-4","article-title":"Polymorphisms in the interleukin- 1b (IL-1B) and interleukin-1a (IL-1A) genes on risk of febrile seizures: A meta-analysis.","volume":"39","author":"Yu","year":"2018","journal-title":"Neurol. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","article-title":"TLR3 deficiency in patients with herpes simplex encephalitis.","volume":"317","author":"Zhang","year":"2007","journal-title":"Science"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1119708\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:51Z","timestamp":1674518451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1119708\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":129,"alternative-id":["10.3389\/fnins.2023.1119708"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1119708","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"article-number":"1119708"}}